| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 823.50M | 912.90M | 584.64M | 325.50M | 213.10M | 103.20M |
| Gross Profit | 543.00M | 0.00 | 335.94M | 195.30M | 78.60M | 63.50M |
| EBITDA | 122.20M | -1.40B | 77.94M | -18.50M | -74.30M | -15.50M |
| Net Income | -1.40B | -1.43B | 27.20M | -48.80M | -91.70M | -21.50M |
Balance Sheet | ||||||
| Total Assets | 7.86B | 8.26B | 6.09B | 3.74B | 2.20B | 1.16B |
| Cash, Cash Equivalents and Short-Term Investments | 1.74B | 2.47B | 1.29B | 783.40M | 509.00M | 340.10M |
| Total Debt | 121.90M | 0.00 | 121.40M | 120.30M | 100.50M | 49.90M |
| Total Liabilities | 7.16B | 7.54B | 5.67B | 3.45B | 1.85B | 899.40M |
| Stockholders Equity | 676.10M | 697.70M | 408.70M | 310.50M | 354.50M | 257.90M |
Cash Flow | ||||||
| Free Cash Flow | 615.70M | 445.10M | 751.10M | 257.30M | 39.00M | 98.00M |
| Operating Cash Flow | 624.80M | 445.10M | 785.50M | 289.90M | 65.70M | 112.70M |
| Investing Cash Flow | -387.20M | -173.60M | -380.10M | -11.70M | -147.50M | -132.50M |
| Financing Cash Flow | 323.20M | 205.80M | 110.30M | 10.30M | 254.70M | 233.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
56 Neutral | $107.54M | 0.95 | 13.52% | ― | 13.16% | ― | |
55 Neutral | $47.54M | 3.50 | 4.33% | ― | 16.79% | ― | |
54 Neutral | $2.59B | -2.18 | -293.98% | ― | ― | ― | |
46 Neutral | $18.87M | 0.17 | 4.56% | ― | 19.30% | -17.56% | |
44 Neutral | $24.62M | -0.09 | -142.05% | ― | 7.56% | -344.04% |
On March 18, 2026, Accelerant reported strong fourth-quarter and full-year 2025 results, with exchange written premium up 24% year over year in the quarter to $1.09 billion and 35% for the full year to $4.19 billion, alongside a 52% rise in adjusted EBITDA in the quarter and 149% for 2025. Third-party direct written premium rose to 40% of exchange volume in the quarter, net income was $0.9 million, and the board approved a share repurchase program of up to $200 million of Class A shares through December 31, 2028, signaling confidence in its growth and capital-light strategy.
The company announced a senior leadership change on March 18, 2026, appointing veteran finance executive Linda S. Huber as chief financial officer, principal financial officer and principal accounting officer effective March 31, 2026, as Jay Green departs in a termination without cause and receives separation benefits under his contract. Huber’s compensation package includes a $650,000 base salary, a guaranteed 2026 bonus, substantial initial and annual equity awards, and restrictive covenants, while the board also disclosed that director Michael Searles resigned on March 13, 2026, ahead of his term’s scheduled expiry in May 2026.
In connection with the governance and capital actions, Accelerant posted an investor presentation to its website on March 18, 2026 to support its fourth-quarter earnings call and frame its outlook for 2026, including expectations for continued double-digit growth in exchange written premium and adjusted EBITDA. Management emphasized the growing role of third-party capital on the Accelerant Risk Exchange and its aim to further scale fee-based, capital-light operations, which could strengthen returns for shareholders and deepen the company’s position in the specialty insurance market.
The most recent analyst rating on (ARX) stock is a Buy with a $13.00 price target. To see the full list of analyst forecasts on Accelerant Holdings Class A stock, see the ARX Stock Forecast page.
Accelerant Holdings plans to hold its 2026 annual general meeting of shareholders on May 12, 2026, with March 13, 2026 set as the record date for determining which shareholders are entitled to vote. The company will provide further logistical details for the meeting in its definitive proxy statement to be filed with the U.S. Securities and Exchange Commission.
The company has set March 9, 2026 as the deadline for shareholders to submit non-director and director nomination proposals for inclusion in, or presentation at, the 2026 meeting, subject to compliance with Cayman Islands law, its Articles of Association and SEC rules. Shareholders who plan to solicit proxies for alternative director nominees under the universal proxy rules must provide the required notice by March 13, 2026, reinforcing a structured and time-bound framework for shareholder participation in corporate governance.
The most recent analyst rating on (ARX) stock is a Buy with a $13.00 price target. To see the full list of analyst forecasts on Accelerant Holdings Class A stock, see the ARX Stock Forecast page.
On February 26, 2026, Accelerant Holdings released preliminary unaudited results indicating strong growth for the fourth quarter and full year ended December 31, 2025, though the figures remain subject to adjustment through the closing and audit process. For the fourth quarter, the company expected Exchange Written Premium of $1.09 billion, up 24% year on year, with Third-Party Direct Written Premium rising to 40% of that total, revenue of about $248 million up 30%, and Adjusted EBITDA of roughly $71 million, a 52% increase.
For full-year 2025, Accelerant projected Exchange Written Premium of $4.19 billion, up 35% from 2024, with Third-Party Direct Written Premium accounting for 30% versus 16% a year earlier. Full-year revenue was expected at $913 million, up 51%, and Adjusted EBITDA at $282 million, a 149% surge, supported in part by irregular investment gains, underscoring rapid scale-up of its specialty insurance platform and a growing mix of third-party business ahead of its detailed earnings release and guidance update planned for March 19, 2026.
The most recent analyst rating on (ARX) stock is a Buy with a $13.00 price target. To see the full list of analyst forecasts on Accelerant Holdings Class A stock, see the ARX Stock Forecast page.